Showing results (111-120 of 181) with videos related to
Sort By:
Pageof 19
Circulation|December 1, 1975
Monitoring for serious arrhythmias and high risk of sudden deathB Lown, A F Calvert, R Armington, et al.The American Journal of Cardiology|February 15, 1990
Changes in cardiac output determined by continuous-wave Doppler echocardiography during propafenone or mexiletine drug testingH Lange, S Lampert, M S Sutton, et al.The American Journal of Cardiology|August 29, 1986
Safety and efficacy of encainide for malignant ventricular arrhythmiasT Tordjman, P J Podrid, E Raeder, et al.Circulation|February 1, 1980
Ethmozin, a new antiarrhythmic drug for suppressing ventricular premature complexesP J Podrid, A Lyakishev, B Lown, et al.Journal of the American College of Cardiology|November 1, 1989
Congestive heart failure induced by six of the newer antiarrhythmic drugsS Ravid, P J Podrid, S Lampert, et al.The American Journal of Cardiology|February 1, 1988
Clinical predictors of arrhythmia worsening by antiarrhythmic drugsW Slater, S Lampert, P J Podrid, et al.The American Journal of Physiology|January 1, 1993
Primary coronary vasodilation associated with pauses in heart rhythm during sleepL W Dickerson, A H Huang, B D Nearing, et al.JAMA|July 17, 1981
Acute psychological disturbances preceding life-threatening ventricular arrhythmiasP Reich, R A DeSilva, B Lown, et al.Lancet (London, England)|October 17, 1981
Lignocaine prophylaxis in acute myocardial infarction: an evaluation of randomised trialsR A DeSilva, C H Hennekens, B Lown, et al.The American Journal of Cardiology|September 1, 1982
Long-term survival of patients with malignant ventricular arrhythmia treated with antiarrhythmic drugsT B Graboys, B Lown, P J Podrid, et al.Pageof 19